DNER and glioblastoma: Over the past twelve years, an increasing body of knowledge has demonstrated that BET proteins play a pro-oncogenic role in GBM biology and have suggested that these epigenetic enzymes could be promising pharmacological targets [132,200,203,204,205,206,207].